Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01354977 · ClinicalTrials.gov registry record · Phase 2
Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
A Phase 2 study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01354977 is a Phase 2 study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 20 participants.
The verdict
NCT01354977, a Phase 2 study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
Resveratrol is a natural polyphenol (a compound containing a phenol functional group) that can be found in many plants. The purpose of this research is to study the effects of resveratrol on the action of insulin (a hormone produced in the body by the pancreas that regulates the amount of sugar in the blood), fat accumulation, and inflammation in the body.
Interventions
- DRUG Resveratrol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-03 |
| Est. Completion | 2017-09-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01354977
The ClinicalTrials.gov registry entry for NCT01354977 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Resveratrol is the first listed.
NCT01354977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01354977 about?
NCT01354977 is a clinical study titled "Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans". Resveratrol is a natural polyphenol (a compound containing a phenol functional group) that can be found in many plants. The purpose of this research is to study the effects of resveratrol on the action of insulin (a hormone produced in the body by the pancreas that regulates the amount of sugar in t...
What is the current status of trial NCT01354977?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2008-03. Estimated completion is 2017-09-15.
What interventions are being tested in trial NCT01354977?
The interventions under investigation include: Resveratrol (DRUG).
Who is sponsoring clinical trial NCT01354977?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.